CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,223
edits
Transmissible Spongiform Encephalopathies Advisory Committee: Difference between revisions
Transmissible Spongiform Encephalopathies Advisory Committee (view source)
Revision as of 22:00, 12 April 2025
, 12 Aprilno edit summary
(Created page with "{{Organization |OrganizationName=Transmissible Spongiform Encephalopathies Advisory Committee |OrganizationType=Boards, Commissions, and Committees |Mission=The mission of the Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) was to provide expert advice to the U.S. Food and Drug Administration (FDA) on policies, regulations, and scientific issues related to transmissible spongiform encephalopathies (TSEs), including bovine spongiform encephalopathy (...") |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Organization | {{Organization | ||
|OrganizationName=Transmissible Spongiform Encephalopathies Advisory Committee | |OrganizationName=Transmissible Spongiform Encephalopathies Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission= | |Mission=Transmissible Spongiform Encephalopathies Advisory Committee advised Food and Drug Administration on policies and science for diseases like mad cow and variant Creutzfeldt-Jakob to ensure safe regulations and protect public health. | ||
|ParentOrganization=Food and Drug Administration | |ParentOrganization=Food and Drug Administration | ||
|TopOrganization=Department of Health and Human Services | |TopOrganization=Department of Health and Human Services | ||
|CreationLegislation=Not established by specific legislation but by FDA authority | |CreationLegislation=Not established by specific legislation but by FDA authority | ||
| | |OrganizationExecutive=Chair | ||
|HeadquartersLocation=38. | |Services=Advisory services; Public health recommendations; Regulatory guidance | ||
|HeadquartersLocation=38.89768, -77.03653 | |||
|HeadquartersAddress=10903 New Hampshire Avenue, Silver Spring, MD 20993, United States | |HeadquartersAddress=10903 New Hampshire Avenue, Silver Spring, MD 20993, United States | ||
|Website=[https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/TransmissibleSpongiformEncephalopathiesAdvisoryCommittee/default.htm fda.gov] | |||
}} | }} | ||
'''Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC)''' was an advisory body to the FDA, focusing on diseases like BSE and vCJD. It provided guidance on the management and regulation of products potentially affected by TSEs, ensuring safety in food, drugs, and biological products. | '''Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC)''' was an advisory body to the FDA, focusing on diseases like BSE and vCJD. It provided guidance on the management and regulation of products potentially affected by TSEs, ensuring safety in food, drugs, and biological products. | ||